A cost-benefit analysis of hospital-wide medication reviews: a period prevalence study
International Journal of Clinical Pharmacy
Background For specific medical specialties it has been shown that clinical pharmacists can have a beneficial effect on the reduction of drug-related problems by performing medication reviews. However, little is known on the cost–benefit ratio of hospital-wide implementation of medication reviews. Aim To investigate the effect of conducting hospital-wide medication reviews on the detection and resolution of drug-related problems, and to calculate the cost–benefit ratio of the intervention. Method In this observational prospective period prevalence study, medication reviews were conducted during five consecutive working days in a Dutch university hospital. Patients admitted for more than 24 h were included. The cost–benefit ratio of conducting the medication reviews was calculated by dividing the total costs by the total savings. Results In 622 medication reviews, 709 potential drug-related problems (1.1 per patient) were detected. The most common advice was to stop medication (38.6%). Patients with a potentially drug-related problem were significantly older, had a higher median number of prescriptions, and the median number of days from admission to the time of medication reviews was longer. Conducting medication reviews showed a positive cost–benefit ratio of 9.7. Conclusions Hospital-wide medication reviews by clinical pharmacists have a positive cost–benefit ratio and contribute to the detection and the resolution of drug related problems (DRPs), mainly by reducing overtreatment.
|International Journal of Clinical Pharmacy|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
S. (Sarah) Wilkes, R.J. (Rianne) Zaal, A. (Alan) Abdulla, & N.G.M. (Nicole) Hunfeld. (2021). A cost-benefit analysis of hospital-wide medication reviews: a period prevalence study. International Journal of Clinical Pharmacy. doi:10.1007/s11096-021-01323-1